Form 4 Filing for BridgeBio Pharma, Inc.
2026-09-21SEC Filing 4 (0001470831-26-000897)
On September 17, 2026, Neil Kumar, Chief Executive Officer and Director of BridgeBio Pharma, Inc. (BBIO), executed a Form 4 filing detailing the sale of 8,721 shares of Common Stock at a weighted average price of $69.0136 per share, and 1,279 shares at a weighted average price of $69.5696 per share. These transactions were conducted under a Rule 10b5-1 sales plan. Following these sales, Kumar